This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
The menopause market size has grown strongly in recent years. It will grow from $17.74 billion in 2024 to $18.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased life expectancy, women's health awareness, nutritional supplements, healthcare access improvement, stress and lifestyle management, patient advocacy.
The menopause market size is expected to see strong growth in the next few years. It will grow to $24.28 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment.
The rising physical inactivity among women is anticipated to boost the growth of the menopause market in the coming years. Physical inactivity, defined as minimal engagement in physical movement - whether during leisure, commuting, or daily tasks - has been linked to worsened menopausal symptoms and increased health risks. This trend has heightened the demand for products and services that help manage menopause-related health issues and support women’s overall well-being. For example, in June 2024, the World Health Organization (WHO) reported that 27% of adults globally were physically inactive in 2022, with this figure expected to reach 35% by 2030. Consequently, the need for targeted solutions in the menopause market continues to grow, driven by the lifestyle and health challenges associated with reduced physical activity among women.
The shift toward healthier lifestyle choices is expected to drive the growth of the menopause market. Lifestyle changes, such as adopting balanced diets, regular exercise, better sleep, reduced alcohol intake, and engaging in stress-relieving activities, can help alleviate menopausal symptoms and promote overall well-being during this natural biological phase. Many women are increasingly focusing on lifestyle adjustments to manage menopause effectively, reflecting a broader trend toward wellness. For instance, a November 2023 report by the Global Wellness Institute, a U.S.-based organization, noted that in 2022, the wellness economy accounted for 5.6% of global economic output, with projections indicating it could grow to $8.5 trillion by 2027 at an average annual growth rate of 8.6%. This trend toward wellness-focused lifestyles is fueling the demand for menopause-related products and services.
Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.
In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.
Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC.
North America was the largest region in the menopause market in 2024. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Menopause is a natural biological process signifying the cessation of a woman's menstrual cycles and reproductive years, officially diagnosed when there is a 12-month absence of a menstrual period. This phase is characterized by various physical and hormonal changes, denoting the conclusion of reproductive capabilities as the ovaries cease egg release, and the hormones progesterone and estrogen decline.
The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.
The menopause market research report is one of a series of new reports that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The menopause market size has grown strongly in recent years. It will grow from $17.74 billion in 2024 to $18.85 billion in 2025 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to increased life expectancy, women's health awareness, nutritional supplements, healthcare access improvement, stress and lifestyle management, patient advocacy.
The menopause market size is expected to see strong growth in the next few years. It will grow to $24.28 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to cognitive health focus, wellness programs at workplace, mental health integration, education and awareness campaigns, personalized medicine. Major trends in the forecast period include digital health solutions for menopause, non-hormonal therapies, research on long-term health outcomes, telemedicine and virtual health, technological innovations in treatment.
The rising physical inactivity among women is anticipated to boost the growth of the menopause market in the coming years. Physical inactivity, defined as minimal engagement in physical movement - whether during leisure, commuting, or daily tasks - has been linked to worsened menopausal symptoms and increased health risks. This trend has heightened the demand for products and services that help manage menopause-related health issues and support women’s overall well-being. For example, in June 2024, the World Health Organization (WHO) reported that 27% of adults globally were physically inactive in 2022, with this figure expected to reach 35% by 2030. Consequently, the need for targeted solutions in the menopause market continues to grow, driven by the lifestyle and health challenges associated with reduced physical activity among women.
The shift toward healthier lifestyle choices is expected to drive the growth of the menopause market. Lifestyle changes, such as adopting balanced diets, regular exercise, better sleep, reduced alcohol intake, and engaging in stress-relieving activities, can help alleviate menopausal symptoms and promote overall well-being during this natural biological phase. Many women are increasingly focusing on lifestyle adjustments to manage menopause effectively, reflecting a broader trend toward wellness. For instance, a November 2023 report by the Global Wellness Institute, a U.S.-based organization, noted that in 2022, the wellness economy accounted for 5.6% of global economic output, with projections indicating it could grow to $8.5 trillion by 2027 at an average annual growth rate of 8.6%. This trend toward wellness-focused lifestyles is fueling the demand for menopause-related products and services.
Prominent companies operating in the menopause market are concentrating on the development of innovative products, exemplified by the introduction of Your Meno Ease Capsules, aiming to better cater to the needs of existing consumers. Your Meno Ease Capsules represent a dietary supplement designed to alleviate menopausal symptoms among women. This supplement comprises a blend of vitamins, minerals, and various nutrients considered beneficial for women experiencing menopause. PharmaLinea Ltd., a Slovenia-based manufacturer specializing in menopausal dietary supplements, introduced Your Meno Ease Capsules in October 2022. This innovative product stands out due to its unique composition and clinically validated functionalities, targeting general alleviation of menopausal symptoms while offering additional benefits for mood, mental acuity, distress management, cardiovascular health, and bone wellness. The capsule contains 75 mg of Qratol, a resveratrol compound with multiple health advantages, along with 40 mg of Qsoy, a soy derivative known for its efficacy in reducing menopausal symptoms, complemented by 1.6 mg of vitamin B6.
In March 2022, Amyris, Inc., a US-based entity specializing in the production and advancement of menopausal pharmaceuticals, acquired MenoLabs LLC in a transaction whose financial details were undisclosed. This strategic acquisition is anticipated to expedite the company's growth trajectory and solidify a prominent standing within the menopausal sector. The incorporation of MenoLabs LLC into Amyris Inc.'s operational framework is expected to leverage the latter's scientific approach in addressing routine health and wellness concerns. MenoLabs LLC, a US-based health and technology enterprise, specializes in the development of treatments targeting menopause-related issues.
Major companies operating in the menopause market report are Pfizer Inc., Johnson & Johnson Inc., The Procter & Gamble Company, F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Abbott Laboratories Ltd., GSK PLC, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Sun Pharmaceutical Industries Limited, Cipla Inc., Dr. Reddy’s Laboratories Ltd., Apotex Inc., Rainbow Light Nutritional Systems LLC, Mithra Pharmaceuticals SA, TherapeuticsMD Inc., Theramex SpA, Pure Encapsulations LLC., Mylan N.V., PADAGIS LLC, Serenity Pharmaceuticals LLC, ASCEND Therapeutics US LLC.
North America was the largest region in the menopause market in 2024. The regions covered in the menopause market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the menopause market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The menopause market includes revenues earned by entities by providing hormone replacement therapies, selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
Menopause is a natural biological process signifying the cessation of a woman's menstrual cycles and reproductive years, officially diagnosed when there is a 12-month absence of a menstrual period. This phase is characterized by various physical and hormonal changes, denoting the conclusion of reproductive capabilities as the ovaries cease egg release, and the hormones progesterone and estrogen decline.
The primary treatments for menopause involve dietary supplements and over-the-counter (OTC) pharmaceutical products. Dietary supplements, distinct from regular food, serve to complement the diet. These treatments are administered topically, orally, or through injectables, and are distributed through channels such as hospitals, retail outlets, and online pharmacies. They cater to end users such as hospitals, diagnostic centers, specialty clinics, and others.
The menopause market research report is one of a series of new reports that provides menopause market statistics, including menopause industry global market size, regional shares, competitors with a menopause market share, detailed menopause market segments, market trends and opportunities, and any further data you may need to thrive in the menopause industry. This menopause market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Menopause Market Characteristics3. Menopause Market Trends and Strategies4. Menopause Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Covid and Recovery on the Market32. Global Menopause Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Menopause Market34. Recent Developments in the Menopause Market
5. Global Menopause Growth Analysis and Strategic Analysis Framework
6. Menopause Market Segmentation
7. Menopause Market Regional and Country Analysis
8. Asia-Pacific Menopause Market
9. China Menopause Market
10. India Menopause Market
11. Japan Menopause Market
12. Australia Menopause Market
13. Indonesia Menopause Market
14. South Korea Menopause Market
15. Western Europe Menopause Market
16. UK Menopause Market
17. Germany Menopause Market
18. France Menopause Market
19. Italy Menopause Market
20. Spain Menopause Market
21. Eastern Europe Menopause Market
22. Russia Menopause Market
23. North America Menopause Market
24. USA Menopause Market
25. Canada Menopause Market
26. South America Menopause Market
27. Brazil Menopause Market
28. Middle East Menopause Market
29. Africa Menopause Market
30. Menopause Market Competitive Landscape and Company Profiles
31. Menopause Market Other Major and Innovative Companies
35. Menopause Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Menopause Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on menopause market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for menopause? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The menopause market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Treatment: Dietary Supplements; Over-The-Counter (OTC) Pharma Products2) By Route Of Administration: Topical; Oral; Injectables
3) By Distribution Channel: Hospital; Retail; Online Pharmacies
4) By End User: Hospital; Diagnostic Centers; Specialty Clinics; Other End Users
Subsegments:
1) By Dietary Supplements: Herbal Supplements; Vitamins And Minerals; Phytoestrogens; Omega-3 Fatty Acids; Probiotics2) By Over-The-Counter (OTC) Pharma Products: Hormone Replacement Therapy (HRT); Non-Hormonal OTC Products; Antidepressants for Mood Swings; Sleep Aids; Pain Relievers
Key Companies Mentioned: Pfizer Inc.; Johnson & Johnson Inc; The Procter & Gamble Company; F. Hoffmann-La Roche AG; Merck & Co. Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
Some of the major companies featured in this Menopause market report include:- Pfizer Inc.
- Johnson & Johnson Inc
- The Procter & Gamble Company
- F. Hoffmann-La Roche AG
- Merck & Co. Inc.
- AbbVie Inc.
- Bayer AG
- Novartis AG
- Sanofi S.A
- Abbott Laboratories Ltd.
- GSK plc
- Eli Lilly and Company
- Amgen Inc.
- Novo Nordisk A/S
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Astellas Pharma Inc.
- Sun Pharmaceutical Industries Limited
- Cipla Inc.
- Dr. Reddy’s Laboratories Ltd.
- Apotex Inc.
- Rainbow Light Nutritional Systems LLC
- Mithra Pharmaceuticals SA
- TherapeuticsMD Inc.
- Theramex SpA
- Pure Encapsulations LLC.
- Mylan N.V.
- PADAGIS LLC
- Serenity Pharmaceuticals LLC
- ASCEND Therapeutics US LLC
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | March 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 18.85 Billion |
| Forecasted Market Value ( USD | $ 24.28 Billion |
| Compound Annual Growth Rate | 6.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 31 |
